Jacobson Pharma Corporation

Jacobson Pharma Corporation ROCE

The Return on Capital Employed (ROCE) of Jacobson Pharma Corporation (2633.HK) as of Nov 5, 2026 is 15.09 %. In the previous year, Return on Capital Employed (ROCE) was 16.74 % — a change of -9.82% (lower).

ROCE

15.09 %

YoY

-9.82%

Last updated:

In 2026, Jacobson Pharma Corporation's return on capital employed (ROCE) was 15.09 %, a -9.82% increase from the 16.74 % ROCE in the previous year.

The Jacobson Pharma Corporation ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
12.62 HKD
Jan 1, 2020
11.34 HKD
Jan 1, 2021
6.49 HKD
Jan 1, 2022
7.54 HKD
Jan 1, 2023
9.80 HKD
Jan 1, 2024
13.90 HKD
Jan 1, 2025
16.74 HKD
Jan 1, 2026
15.09 HKD
The Jacobson Pharma Corporation ROCE history
YEARROCEYoY
15.09 %-9.82%
16.74 %+20.38%
13.90 %+41.87%
9.80 %+30.04%
7.54 %+16.18%
6.49 %-42.79%
11.34 %-10.16%
12.62 %-9.55%
13.95 %-2.73%
14.34 %-30.02%
20.49 %+48.59%
13.79 %-43.26%
24.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jacobson Pharma Corporation Stock analysis

What does Jacobson Pharma Corporation do? Jacobson Pharma Corp. Ltd. generates revenue through its Generic Drugs segment, which develops, manufactures, and distributes off-patent medicines for public and private sectors. The Branded Healthcare segment offers branded medicines, proprietary Chinese medicines, and health and wellness products. Both segments operate primarily in Hong Kong, serving healthcare providers and consumers seeking cost-effective pharmaceutical solutions. The company employs 1,789 full-time employees to support its operations across these segments. The Generic Drugs segment focuses on off-patent medicines for various therapeutic uses, targeting hospitals, clinics, and pharmacies in both public and private healthcare systems. The Branded Healthcare segment caters to consumers and healthcare providers through branded pharmaceuticals and wellness products, emphasizing proprietary Chinese medicines as a key offering. Revenue streams are derived from direct sales of these products within Hong Kong's healthcare market. Jacobson Pharma's business model relies on the dual revenue streams from generic and branded pharmaceuticals. The company's product portfolio includes off-patent medicines under the Generic Drugs segment and branded medicines under the Branded Healthcare segment, both contributing to its overall sales. The firm's operations are structured around these two segments, with all activities concentrated in Hong Kong. Jacobson Pharma Corporation is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Jacobson Pharma Corporation's Return on Capital Employed (ROCE)

Jacobson Pharma Corporation's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Jacobson Pharma Corporation's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Jacobson Pharma Corporation's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Jacobson Pharma Corporation’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Jacobson Pharma Corporation stock

Return on Capital Employed (ROCE) of Jacobson Pharma Corporation is 15.09 % in 2026.

Return on Capital Employed (ROCE) of Jacobson Pharma Corporation changed from 16.74 % to 15.09 %, representing a -9.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Jacobson Pharma Corporation since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Jacobson Pharma Corporation with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Jacobson Pharma Corporation

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Jacobson Pharma Corporation